Eubacterium limosum
Selected indexed studies
- Eubacterium limosum as a biocatalyst for sustainable methanol bioconversion. (Curr Opin Biotechnol, 2025) [PMID:40934833]
- Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer. (ISME J, 2025) [PMID:40568973]
- Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites. (Gastroenterology, 2023) [PMID:37704113]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites. (2023) pubmed
- Gut symbiont-derived ursodeoxycholic acid promotes fatty acid oxidation to protect against renal ischemia-reperfusion injury. (2025) pubmed
- Eubacterium limosum as a biocatalyst for sustainable methanol bioconversion. (2025) pubmed
- Eubacterium limosum modulates tumor microenvironments and produces antitumor metabolites active against colorectal cancer. (2025) pubmed
- Eubacterium limosum modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis. (2025) pubmed
- Characterisation of acetogen formatotrophic potential using Eubacterium limosum. (2023) pubmed
- Genome Engineering of Eubacterium limosum Using Expanded Genetic Tools and the CRISPR-Cas9 System. (2019) pubmed
- Deletion of biofilm synthesis in Eubacterium limosum ATCC 8486 improves handling and transformation efficiency. (2023) pubmed
- Genome Sequence of Eubacterium limosum B2 and Evolution for Growth on a Mineral Medium with Methanol and CO(2) as Sole Carbon Sources. (2022) pubmed
- High methanol-to-formate ratios induce butanol production in Eubacterium limosum. (2022) pubmed